Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pulmonary Embolism × Deoxyribonucleases × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pulmonary Embolism 1 Pneumothorax 1 Pleural Effusion 1 Pleural Diseases 1 Lung Neoplasms 1

Interventions

apixaban 7 Dalteparin 7 Tinzaparin 3 edoxaban 2 abelacimab 2 MAA868 2 Heparin, Low-Molecular-Weight 2 Enoxaparin 2 Dabigatran 2 perflutren 1 bemiparin 1 Warfarin 1 Sulfur Hexafluoride 1 Rosuvastatin Calcium 1 Rivaroxaban 1 Hospitals 1 Fondaparinux 1 Fluorodeoxyglucose F18 1 Educational Status 1 Deoxyribonucleases 1 4-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03167281 2025-02-21

ELEVATE

Prisma Health-Midlands

Phase 4 Withdrawn

Lung Neoplasms, Pleural Diseases, Pleural Effusion, Pneumothorax, Pulmonary Embolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡